The latest closing stock price for Stoke Therapeutics as of September 19, 2024 is 15.14.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-408 today, roughly 0 times their original investment - a -9.95% compound annual growth rate over 5 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 16.1% above the current share price.
The Stoke Therapeutics 52-week low stock price is 3.35, which is 77.9% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 9.34.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-408 today, roughly 0 times their original investment - a -9.95% compound annual growth rate over 5 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 16.1% above the current share price.
The Stoke Therapeutics 52-week low stock price is 3.35, which is 77.9% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 9.34.